Search Within

Neeta Pandit-Taskar

Formats
  1. Meeting Abstract (156)
  2. Journal Article (142)
  3. Review (20)
  4. Book Section (17)
  5. Guidelines (5)
  6. Editorial (2)
Groups
  1. Molecular Imaging and Therapy Service (342)
  2. Radiology, Department of (342)
  3. GSK Faculty (145)
  4. Medical Physics (126)
  5. Department of Medicine (120)
  6. Molecular Pharmacology and Chemistry Program Faculty (103)

More Groups

People
  1. Steven Larson (99)
  2. Jorge Carrasquillo (77)
  3. Pat Zanzonico (57)
  4. Jason Lewis (52)
  5. Serge Lyashchenko (52)
  6. Kim Kramer (51)

More People

Years
  1. 2025 (5)
  2. 2024 (21)
  3. 2023 (31)
  4. 2022 (33)
  5. 2021 (21)
  6. 2020 (12)

More Years

Publications
  1. Journal of Nuclear Medicine (66)
  2. Journal of Clinical Oncology (48)
  3. European Journal of Nuclear Medicine and Molecular Imaging (21)
  4. Pediatric Blood and Cancer (21)
  5. Neuro-Oncology (20)
  6. Blood (13)

More Publications

Publishers
  1. Society of Nuclear Medicine (66)
  2. Springer (49)
  3. American Society of Clinical Oncology (48)
  4. Elsevier Inc. (38)
  5. Oxford University Press (23)
  6. Wiley Periodicals, Inc (21)

More Publishers

Results (342)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Administration and radiation safety of high-dose Iomab-B (I131-apamistamab) demonstrated in multiple clinical settings: Experience from the large multicenter phase 3 SIERRA trial for targeted conditioning of patients with relapsed/refractory AML
    Meeting Abstract

    Serencsits, B.; Prasad, K.; Chen, L.; Senglaub, T.; Zgaljardic, M.; Brodin, P.; McNamara, K.; Desai, A.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Streamlining personalized dosimetry for I131-apamistamab using a Co-57 sheet source to circumvent the need for radionuclide-specific attenuation correction
    Meeting Abstract

    Schwartz, J.; Brodin, P.; Spross, J.; Haeuber, E.; Fisher, D.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • TITLE: A pilot study of 89Zr-DFO-REGN3767 anti-LAG-3 antibody positron emission tomography in patients with diffuse large B-cell lymphoma
    Meeting Abstract

    Pandit-Taskar, N.; Shutian, R.; Grkovski, M.; Schwartz, J.; Lyashchenko, S.; Cheung, K.; Uldrick, T.; Ma, D.; Giurleo, J.; Palomba, L.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • 18F-MFBG PET imaging in patients with neuroblastoma: Lesion targeting and comparison with MIBG
    Meeting Abstract

    Pandit-Taskar, N.; Mauguen, A.; Basu, E.; Price, A.; Behr, G.; Min, R.; Lyashchenko, S.; Schwartz, J.; Modak, S.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Machine learning applications to optimize dosimetric imaging of I131-apamistamab for bone marrow conditioning in relapsed/refractory acute myeloid leukemia (R/R AML)
    Meeting Abstract

    Brodin, P.; Schwartz, J.; Wang, W.; Spross, J.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Determination of the treatment coverage of theragnostic (124)I-8H9 antibody to treat diffuse pontine glioma by convective enhance delivery
    Meeting Abstract

    Velo, A. F.; Larsen, A. G.; Humm, J.; Zanzonico, P.; Souweidane, M.; Pandit-Taskar, N.
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Feasibility of high- dose targeted radiation with I131apamistamab in patients with relapsed/refractory AML: Dosimetry and radiation safety experience from the phase 3 SIERRA trial
    Meeting Abstract

    Pandit-Taskar, N.; Prasad, K.; Chen, L.; Senglaub, T.; Zgaljardic, M.; Brodin, P.; Serencsits, B.
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • (89)Zr-DFO-girentuximab PET/CT imaging for clear cell renal cell carcinoma - ZIRCON study results of diagnostic performance, including in very small lesions
    Meeting Abstract

    Martina, S.; Mulders, P.; Shuch, B. M.; Pantuck, A. J.; Morris, M. A.; Master, V.; Scott, A.; Van Praet, C.; Bailly, C.; Onal, B.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Safety and dosimetry evaluation of personalized dose I131-apamistamab prior to HCT in the phase 3 SIERRA trial for patients with relapsed/refractory acute myeloid leukemia (R/R AML)
    Meeting Abstract

    Pandit-Taskar, N.; Natwa, M.; Chen, M.; Yap, W.; Wiseman, G.; Leung, E.; Desai, A.; Brodin, P.; Haeuber, E.; Nahar, A.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save